TTE: this trial you speak of is actually happening right now. 1500 patients. There are 300+ patients currently enrolled. Full enrollment anticipated within 2-3 weeks. The trial will run for a couple of weeks with data soon there after. The patient needs to have been exposed
I’m sure I’m missing details. However this is what I picked up from the interview